Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.13 | N/A |
| PEG Ratio (TTM) | -0.57 | N/A |
| P/S Ratio (TTM) | 0.62 | N/A |
| P/B Ratio (TTM) | 0.40 | N/A |
| P/FCF Ratio (TTM) | 39.92 | N/A |
| Price to 5YR AVG Earnings Ratio | 7.94 | N/A |
| Price to 5YR AVG FCF Ratio | 5.27 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.12% | N/A |
| ROE (TTM) | 2.85% | N/A |
| Net Profit Margin (TTM) | 4.29% | N/A |
| ROIC 5YR AVG | 5.40% | N/A |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 10.03% | 180.23% | 104.97% |
| Revenue | -0.26% | -3.49% | -1.26% |
| Net Income | 11.26% | 188.60% | 110.31% |
| Cash Flow | 80.38% | 1.63% | -3.14% |
Health (74%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.64 | N/A |
| Quick Ratio (TTM) | 2.64 | N/A |
| D/E Ratio (TTM) | 0.03 | N/A |
| Interest Coverage (TTM) | 14.99 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 2.29 | N/A |
| LTL to 5YR AVG FCF | 0.42 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.73% | N/A |